Literature DB >> 21515565

Prevalence of diabetic retinopathy, cataract and visual impairment in patients with diabetes in sub-Saharan Africa.

Simon J Glover1, Philip I Burgess, Danielle B Cohen, Simon P Harding, Helma W C Hofland, Eduard E Zijlstra, Theresa J Allain.   

Abstract

BACKGROUND/AIMS: There are few published data on the prevalence of diabetic retinopathy in sub-Saharan Africa. We report the prevalence of all grades of retinopathy and associations with systemic parameters in patients attending a secondary care diabetes clinic in Blantyre, Malawi.
METHODS: Cross-sectional study of all patients attending for diabetes care in a hospital setting. Clinical examination and biochemical testing was performed to assess visual acuity (VA), grade of retinopathy (slit lamp biomicroscopy), microvascular complications, glycaemic control, hypertension and HIV status. Sight-threatening diabetic retinopathy (STDR) was defined as moderate preproliferative retinopathy or worse, circinate maculopathy or exudates within one disc diameter of the foveal centre or clinically significant macular oedema.
RESULTS: In patients with type 2 diabetes (n=249) the prevalence (95% CI) of any retinopathy, STDR and proliferative diabetic retinopathy (PDR) was 32.5% (26.7 to 38.3%), 19.7% (14.7 to 24.6%) and 4.8% (2.2 to 7.5%), respectively. The presence of STDR was associated with albuminuria (OR 2.6; p=0.02), the presence of neuropathy (OR 3.4; p=0.005) and insulin use (OR 5.3; p=0.0004), but not with HIV status. In patients with type 1 diabetes (n= 32), the prevalence of any retinopathy, STDR and PDR was 28.1% (12.5 to 43.7%), 18.8% (5.2 to 32.2%) and 12.5% (1.0 to 24.0%), respectively. 12.1% of study subjects had VA worse than 6/18 (20/60).
CONCLUSION: This study provides baseline information on prevalence of all grades of retinopathy and STDR in consecutive cases attending an urban/semi-urban diabetes clinic in sub-Saharan Africa. Prevalence of STDR was high and in type 2 diabetes was associated with albuminuria, neuropathy and insulin use.

Entities:  

Mesh:

Year:  2011        PMID: 21515565     DOI: 10.1136/bjo.2010.196071

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  27 in total

1.  Management of diabetic retinopathy.

Authors:  D Ellis; P I Burgess; P Kayange
Journal:  Malawi Med J       Date:  2013-12       Impact factor: 0.875

2.  Improvement of visual acuity based on optical coherence tomography patterns following intravitreal bevacizumab treatment in patients with diabetic macular edema.

Authors:  Haider R Cheema; Ahmed Al Habash; Essam Al-Askar
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

3.  Prevalence of diabetic retinopathy and visual impairment in patients with diabetes mellitus in Zambia through the implementation of a mobile diabetic retinopathy screening project in the Copperbelt province: a cross-sectional study.

Authors:  Adam D Lewis; Ruth E Hogg; Manju Chandran; Lillian Musonda; Lorraine North; Usha Chakravarthy; Sobha Sivaprasad; Geeta Menon
Journal:  Eye (Lond)       Date:  2018-03-05       Impact factor: 3.775

4.  Demographic features and visual outcomes of patients presenting to diabetic photo-screening and treated for sight threatening retinopathy in Fiji.

Authors:  Riyaz Bhikoo; Neil Murray; Biu Sikivou; Stephanie Emma; Charles McGhee
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

Review 5.  The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care.

Authors:  Katherine Samaras
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

6.  Prevalence, Awareness and Determinants of Diabetic Retinopathy in a Screening Centre in Nigeria.

Authors:  Nkiru N Kizor-Akaraiwe; Ifeoma R Ezegwui; Ngozi Oguego; Nkechi J Uche; Ifeoma N Asimadu; Jude Shiweobi
Journal:  J Community Health       Date:  2016-08

7.  Visual impairment and blindness in type 2 diabetics: Ife-Ijesa diabetic retinopathy study.

Authors:  O H Onakpoya; B A Kolawole; A O Adeoye; B O Adegbehingbe; O Laoye
Journal:  Int Ophthalmol       Date:  2015-11-04       Impact factor: 2.031

Review 8.  Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review.

Authors:  P I Burgess; I J C MacCormick; S P Harding; A Bastawrous; N A V Beare; P Garner
Journal:  Diabet Med       Date:  2013-04       Impact factor: 4.359

Review 9.  Epidemiological issues in diabetic retinopathy.

Authors:  Peter H Scanlon; Stephen J Aldington; Irene M Stratton
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

10.  The global burden of visual difficulty in low, middle, and high income countries.

Authors:  Ellen E Freeman; Marie-Hélène Roy-Gagnon; Elodie Samson; Slim Haddad; Marie-Josée Aubin; Claudia Vela; Maria Victoria Zunzunegui
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.